TOP 5 in Infectious Diseases - International Symposium

  • Tipologia RES
  • Data 08/03/2024
    09/03/2024
    10/03/2024
  • Luogo HOTEL MONACO & GRAND CANAL - San Marco 1332 - Venice (Italy)
  • Programma Visualizza
Immagine evento

Razionale

TOP 5 in Infectious Diseases

Innovation. This is the word that inspires the TOP5 Congress in Venice. This event is organized to find new solutions for different challenges in infectious diseases and to bring current global issues to the attention of institutions.
Nowadays, in the era of globalization, innovation in infectious diseases is crucial to find new weapons against several threats. The challenges in the treatment of infectious diseases will be discussed in a scientific and public debates. The following topics will be covered:

1. Antimicrobial resistant microrganisms. The global spread of multidrug resistant organisms (MDRO) causing severe infections in both the community and nosocomial setting is a threat for public health. Innovative strategies are needed to implement early diagnosis and optimal/appropriate use of new available antibiotics.
2. COVID-19 is not over and frail patients continued to be at increased risk of severe outcomes subsequent to SARS CoV-2 infection. Implementation of new strategies (monoclonal antibodies, vaccines, antivirals) is crucial to prevent and treat COVID-19. New vaccine platforms represent innovative strategies that should be appropriately applied to the clinical setting.
3. HIV still represents an ongoing challenge. Increase in late presentation of HIV infection poses the scientific community in front of the need for implementation of pre-exposure prophylaxis, testing and early HIV infection diagnosis. Moreover, the complexity of HIV-positive people highlights the need for tailored therapeutic approaches.
4. Beyond the ambitious goal of HCV eradication, emergence of delta virus as cause of hepatitis and presence of coinfections (such as HIV and HBV) poses new challenges that should be addressed.
5. Fungi are evolving and new multidrug resistant species spread around the world. New antifungals are needed to overcome resistance in yeast and molds infections.

But what does “innovation” mean in these 5 field of Infectious Diseases? Innovation means “appropriate and rational use” of diagnostic methods, antimicrobials, Big Data and maching learning finalized to develop updated knowledge and new solutions for the treatment of Infectious Diseases in the modern era. These issues should be discussed with academicians, stakeholders, professionals and young researchers to share experiences and evidences and to have an unforgettable experience in Venice.

Obiettivo Formativo

2 – Linee guide – protocolli - procedure

Responsabile Scientifico

Presidente

Prof. Marco Falcone

Professore Ordinario di Malattie Infettive 
Direttore U.P. Clinica e Terapia delle Infezioni Altamente Diffusive e resistenti agli Antimicrobici e della U.O.
di Malattie Infettive Azienda Ospedaliera Universitaria Pisana
Direttore Scuola di Specializzazione in Malattie Infettive, Università di Pisa
Segretario della Società Italiana di Malattie Infettive e Tropicali (SIMIT)
Presidente dell'ESCMID Study Group for Infections in the Elderly (ESGIE)

Segreteria Scientifica

Prof.ssa Annamaria Cattelan
Direttore Unità Op. Complessa Malattie Infettive e Tropicali,
Az. Ospedaliera di Padova
Padova

Prof.ssa Cristina Mussini
Professore Ordinario di Malattie Infettive / 
Direttore della Clinica delle Malattie Infettive e Tropicali, 
Università di Modena e Reggio Emilia
A.O.U. Policlinico di Modena
Modena

Dr.ssa Giusy Tiseo
Dirigente Medico in Malattie Infettive
Azienda Ospedaliero Universitaria Pisana
Pisa

Dr. Sandro Panese
Direttore dell'Unità Operativa di Malattie Infettive
Azienda Ulss 3 Serenissima
Mestre (VE)


Faculty

Najy Alsayed - Menarini Group, Florence, Italy
Maurizio Amato - Board Member Federchimica Assobiotec
Andrea Antinori - INMI Spallanzani, Rome, Italy
Michele Bartoletti - Humanitas University of Milan, Italy
Matteo Bassetti - University of Genoa, Italy
Stefano Bonora - University of Turin, Italy
Alberto Borghetti - University of Pisa, Italy
Maurizia Rossana Brunetto - University of Pisa, Italy
Raffaele Bruno - University of Pavia, Italy
Alessio Butti- Undersecretary to the Presidency of the Council
of Ministers, Italy
Tonia Cartolano - Journalist, Sky tg24, Italy
Antonella Castagna - San Raffaele University of Milan, Italy
Anna Maria Cattelan - University of Padua, Italy
Davide Corti - HUMABS Biomed, Bellinzona, Swiss
Andrea Cossarizza - University of Modena, Italy
Frederico da Silva - Vice President & General Manager, Gilead Sciences
Francesco De Rosa - University of Turin, Italy
Steven Deeks - University of California, San Francisco, USA
Gabriella D'Ettorre - La Sapienza University of Rome, Italy
Guido Di Donato - Italy Health and Value Senior Director, Pfizer Italy
Giovanni Di Perri - University of Turin, Italy
Marco Falcone - University of Pisa, Italy
Emanuele Focà - University of Brescia, Italy
Marcello Gemmato - Sottosegretario Ministry of Health, Italy
Ivan Gentile - University of Naples, Italy
Maddalena Giannella - University of Bologna, Italy
Andrea Gori - L. Sacco Hospital, University of Milan, Italy
Souha Kanj - American University of Beirut, Lebanon
Fabio Landazabal - President of Farmindustria Prevention Group, Italy
Leonard Leibovici - University of Tel Aviv, Israel
Alberto Mantovani - Humanitas University of Milan, Italy
Giulia Marchetti - University of Milan, Italy
Esteban Martinez - University of Barcelona, Spain
Claudio Maria Mastroianni - La Sapienza University of Rome, Italy
Francesco Menichetti - G.I.S.A. President, Italy
Marianna Meschiari - University of Modena, Italy
Jovana Milic - University of Modena, Italy
Patricia Muñoz - Hospital Universitario G. Maranon, Madrid, Spain
Cristina Mussini - University of Modena, Italy
Silvia Nozza - San Raffaele University of Milan, Italy
Ali Omrani - Quatar University, Doha, Qatar
Fausto Orsomarso - Senator Italian Parliament
Chloe Orkin - Queen Mary University of London, UK
Saverio Parisi - University of Padua, Italy
Francesca Patarnello - Vice President Market Access & Government
Affairs, AstraZeneca Italy
David Paterson - University of Singapore, Republic of Singapore
Mical Paul - Rambam Health Care Campus, Haifa, Israel
Andrea Pitrelli - Market Access & Government Affairs Head, Shionogi, Italy
Jason Pogue - University of Michigan College of Pharmacy, Ann Arbor, USA
Rino Rappuoli - Biotechnopole Foundation of Siena, Italy
Joseph Ross - Yale University, New Haven, CT, USA
Gian Maria Rossolini - University of Florence, Italy
Alessandro Russo - University of Catanzaro, Italy
Federico Serra - Segreteria Tecnica Intergruppo Parlamentare
Prevenzione e Controllo delle Malattie Infettive e Tropicali
Carlo Signorelli - President National Immunization Technical
Advisory Group (NITAG)
Alex Soriano - Hospital Clinic de Barcelona, University of Barcelona, Spain
Serafino Sorrenti, Chief Innovation Officer, Dipartimento per la
Trasformazione Digitale, Presidenza del Consiglio dei Ministri
Justin Stebbing - Imperial College, London, UK
Stefania Stefani - University of Catania, Italy
Gina Suh - Mayo Clinic, Rochester, MN, USA
Pierre Tattevin - Rennes University Hospital, Rennes, France
Giusy Tiseo - University of Pisa, Italy
Carlo Torti - Catholic University, Rome, Italy
Mario Tumbarello - University of Siena, Italy
Adolfo Urso - Minister of Enterprises and Made in Italy, Italy
Francesco Vaia - Ministry of Health, Italy
David Van Duin - UNC School of Medicine, Chapel Hill, NC, USA
Antonio Vena - University of Genoa, Italy
Mario Venditti - La Sapienza University of Rome, Italy
Pierluigi Viale - University of Bologna, Italy
Dafna Yahav - Rabin Medical Center, Beilinson Hospital, Petah-Tiqva, Israel

Attività obbligatorie

Crediti Formativi (ECM)

L’assegnazione dei crediti è subordinata alla presenza del 90% dei lavori.

Al termine della giornata è obbligatorio la compilazione dei seguenti moduli online:

  • questionario di verifica apprendimento ECM;
  • scheda valutazione evento;
  • scheda fabbisogni formativi;

Cliccando sul bottone ISCRIVITI, se l’utente non ha effettuato login viene rimandato alla relativa pagina all’interno della quale deve obbligatoriamente inserire le credenziali di accesso per potersi iscrivere all’evento,

Se già effettuato login, verrà visualizzata apposita pagina riepilogativa del corso,

  • Data: 8 marzo 2024
  • Orario: 09:00 - 19:00
  • Data: 9 marzo 2024
  • Orario: 09:00 - 16:30
  • Data: 10 marzo 2024
  • Orario: 09:30 - 13:30
  • Durata: 3 giorni
  • Sito: top5id.it
  • Crediti ECM: 17 crediti
  • Iscrizione Evento: su invito
  • Partecipanti: 100
  • Tipologia: RES
  • ID ECM: 265-404862
  • Provider ECM: 265
  • Ore formative: 17

Vuoi partecipare a questo evento?

Solo gli utenti registrati al sito possono partecipare.

Accedi Registrati
image
Con il contributo educazionale non condizionante di:
Vuoi rimanere sempre aggiornato sui nostri eventi & corsi?

Iscriviti alla NEWSLETTER NADIREXECM.IT

Il nostro team

Contattaci